Publish in this journal
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Olga Sanchez-Pernautea,
Corresponding author
osanchez@fjd.es

Corresponding author.
, Fredeswinda I. Romero-Buenoa, Albert Selva-O’Callaghanb
a Rheumatology Division, Jiménez Díaz Foundation University Hospital and Health Research Institute, Universidad Autónoma de Madrid, Madrid, Spain
b Department of Internal Medicine, Hospital Universitari Val d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
Read
48
Times
was read the article
4
Total PDF
44
Total HTML
0
Total EPUB
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2021 November 44 4 0 48
2021 October 0 0 0 0

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?